Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOTÂ®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Past Team (2)Update
Funding Rounds (4) - $106.6MUpdate
Clarus Ventures is a life sciences venture capital firm.
Health-Care Focused VC Firm
Invesco is a leading independent global investment manager, dedicated to helping investors...
SPARK Ventures, formerly NewMediaSpark, is an early-stage venture capital investor in Europe,...
Healthcare Investment Group
DFJ Esprit is a Pan-European venture capital fund that invests into disruptive tech companies at...
Wellington Partners is a venture capital firm that invests in technology and life sciences...
Oxford Immunotec Inc.
2 Mount Royal Avenue, Suite 100
Marlborough, MA MA 01792
Oxford Immunotec D&M
94C Milton Park
Abingdon, OX14 4RY
Oxford Immunotec HQ
115D Milton Park
Abingdon, OX14 4RZ
- 08/05/14 -genengnews.com
- 11/22/13 -nasdaq.com